Sign in

CIK 0000072444

  • Accelerated filer
  • Smaller reporting company

Vaxart, Inc.

Sign in to watch
Ticker
VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
591212264
Phone
+1 650-550-3500
Business address
310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-07-16 Finney Kevin Director Grant or award +39,400 244,171
2026-07-16 Finney Kevin Director Grant or award · Stock Options (right to buy) +78,700 78,700
2025-08-15 Finney Kevin Director Purchase +50,000 $0.35 $18K 154,771
2025-08-15 Finney Kevin Director Purchase +50,000 $0.37 $19K 204,771
2025-07-30 Finney Kevin Director Purchase +25,874 $0.38 $10K 104,771
2025-07-28 Finney Kevin Director Purchase +20,000 $0.40 $8K 78,897
2025-07-25 Finney Kevin Director Purchase +20,000 $0.39 $8K 58,897
2025-07-17 Finney Kevin Director Purchase +794 $0.38 $302 38,897
2025-06-13 Finney Kevin Director Grant or award +6,103 38,103
2025-06-13 Finney Kevin Director Grant or award · Stock Option (right to buy) +36,392 36,392
2025-01-28 Finney Kevin Director Grant or award +32,000 32,000
2025-01-28 Finney Kevin Director Grant or award · Stock Option (right to buy) +190,800 190,800

Page 1 of 1 · 12 trades